-
1
-
-
0016638259
-
Tamoxifen (ICI 46,474) and the human carcinoma 8S oestrogen receptor
-
Jordan VC, Koerner S. Tamoxifen (ICI 46,474) and the human carcinoma 8S oestrogen receptor. Eur J Cancer 1975;11:205-6.
-
(1975)
Eur J Cancer
, vol.11
, pp. 205-206
-
-
Jordan, V.C.1
Koerner, S.2
-
2
-
-
0017665570
-
A monohydroxylated metabolite of tamoxifen with potent antioestrogenic activity
-
Jordan VC, Collins MM, Rowsby L, Prestwich G. A monohydroxylated metabolite of tamoxifen with potent antioestrogenic activity. J Endocrinol 1977;75:305-16.
-
(1977)
J Endocrinol
, vol.75
, pp. 305-316
-
-
Jordan, V.C.1
Collins, M.M.2
Rowsby, L.3
Prestwich, G.4
-
3
-
-
0020003085
-
Tamoxifen and metabolites in MCF-7 cells: Correlation between binding to estrogen receptor and inhibition of cell growth
-
Coezy E, Borgna JL, Rochefort H. Tamoxifen and metabolites in MCF-7 cells: correlation between binding to estrogen receptor and inhibition of cell growth. Cancer Res 1982;42:317-23.
-
(1982)
Cancer Res
, vol.42
, pp. 317-323
-
-
Coezy, E.1
Borgna, J.L.2
Rochefort, H.3
-
4
-
-
0023710675
-
Characterization of insulin-like growth factor (IGF-I) receptors of human breast cancer cells
-
Pollak MN, Polychronakos C, Yonsefi S, Richard M. Characterization of insulin-like growth factor (IGF-I) receptors of human breast cancer cells. Biochem Biophys Res Commun 1988;154:326-31.
-
(1988)
Biochem Biophys Res Commun
, vol.154
, pp. 326-331
-
-
Pollak, M.N.1
Polychronakos, C.2
Yonsefi, S.3
Richard, M.4
-
6
-
-
0026671209
-
The insulin-like growth factor family of ligands, receptors and binding proteins
-
Krywicki RF, Yee D. The insulin-like growth factor family of ligands, receptors and binding proteins. Breast Cancer Res Treat 1992;22:7-19.
-
(1992)
Breast Cancer Res Treat
, vol.22
, pp. 7-19
-
-
Krywicki, R.F.1
Yee, D.2
-
7
-
-
0026576726
-
Insulin-like growth factors and cancer
-
Macaulay VM. Insulin-like growth factors and cancer. Br J Cancer 1992;65:311-20.
-
(1992)
Br J Cancer
, vol.65
, pp. 311-320
-
-
Macaulay, V.M.1
-
8
-
-
0024408247
-
Growth inhibition of human breast cancer cells in vitro with an antibody against the type I somatomedin receptor
-
Arteaga CL, Osborne CK. Growth inhibition of human breast cancer cells in vitro with an antibody against the type I somatomedin receptor. Cancer Res 1989;49:6237-41.
-
(1989)
Cancer Res
, vol.49
, pp. 6237-6241
-
-
Arteaga, C.L.1
Osborne, C.K.2
-
9
-
-
0024460381
-
Blockade of the type I somatomedin receptor inhibits growth of human breast cancer cells in athymic mice
-
Arteaga CL, Kitten LJ, Coronado EB, Jacobs S, Kull FC, Alfred DC, Osborne CK. Blockade of the type I somatomedin receptor inhibits growth of human breast cancer cells in athymic mice. J Clin Invest 1989;84:1418-23.
-
(1989)
J Clin Invest
, vol.84
, pp. 1418-1423
-
-
Arteaga, C.L.1
Kitten, L.J.2
Coronado, E.B.3
Jacobs, S.4
Kull, F.C.5
Alfred, D.C.6
Osborne, C.K.7
-
10
-
-
0027496222
-
Estrogen and antiestrogen modulation of MCF7 human breast cancer cell proliferation is associated with specific alterations in accumulation of insulin-like growth factorbinding proteins in conditioned media
-
Pratt SE, Pollak MN. Estrogen and antiestrogen modulation of MCF7 human breast cancer cell proliferation is associated with specific alterations in accumulation of insulin-like growth factorbinding proteins in conditioned media. Cancer Res 1993;53:5193-98.
-
(1993)
Cancer Res
, vol.53
, pp. 5193-5198
-
-
Pratt, S.E.1
Pollak, M.N.2
-
11
-
-
0024539364
-
Effect of tamoxifen on plasma insulin-like growth factor-I in patients with breast cancer
-
Colletti RB, Roberts JD, Devlin JT, Copeland KC. Effect of tamoxifen on plasma insulin-like growth factor-I in patients with breast cancer. Cancer Res 1989;49:1882-84.
-
(1989)
Cancer Res
, vol.49
, pp. 1882-1884
-
-
Colletti, R.B.1
Roberts, J.D.2
Devlin, J.T.3
Copeland, K.C.4
-
12
-
-
0025611672
-
Effect of tamoxifen on serum insulin-like growth factor I levels in stage I breast cancer patients
-
Pollak M, Constantino J, Polychronakos C, et al. Effect of tamoxifen on serum insulin-like growth factor I levels in stage I breast cancer patients. J Natl Cancer Inst 1990;82:1693-97.
-
(1990)
J Natl Cancer Inst
, vol.82
, pp. 1693-1697
-
-
Pollak, M.1
Constantino, J.2
Polychronakos, C.3
-
13
-
-
0027229625
-
Suppression of serum insulin-like growth factor-I levels in breast cancer patients during adjuvant tamoxifen therapy
-
Friedl A, Jordan VC, Pollak M. Suppression of serum insulin-like growth factor-I levels in breast cancer patients during adjuvant tamoxifen therapy. Eur J Cancer 1993;29A:1368-72.
-
(1993)
Eur J Cancer
, vol.29 A
, pp. 1368-1372
-
-
Friedl, A.1
Jordan, V.C.2
Pollak, M.3
-
14
-
-
0026779758
-
Influence of tamoxifen on plasma levels of insulin-like growth factor-I and insulin-like growth factor binding protein I in breast cancer patients
-
Lønning PE, Hall K, Aakvaag A, Lien EA. Influence of tamoxifen on plasma levels of insulin-like growth factor-I and insulin-like growth factor binding protein I in breast cancer patients. Cancer Res 1992;52:4719-23.
-
(1992)
Cancer Res
, vol.52
, pp. 4719-4723
-
-
Lønning, P.E.1
Hall, K.2
Aakvaag, A.3
Lien, E.A.4
-
15
-
-
0024213180
-
Radioimmunoassay of a 26,000-dalton plasma insulin-like growth factor binding protein: Control by nutritional variables
-
Busby WH, Snyder DK, Clemmons DR. Radioimmunoassay of a 26,000-dalton plasma insulin-like growth factor binding protein: control by nutritional variables. J Clin Endocrinol Metab 1988;67: 1225-30.
-
(1988)
J Clin Endocrinol Metab
, vol.67
, pp. 1225-1230
-
-
Busby, W.H.1
Snyder, D.K.2
Clemmons, D.R.3
-
16
-
-
0027293212
-
The regulation of insulin-like growth factor binding (IGFBP)-1 during prolonged fasting
-
Cotterill AM, Holly JMP, Wass JAH. The regulation of insulin-like growth factor binding (IGFBP)-1 during prolonged fasting. Clin Endocrinol 1993;39:357-62.
-
(1993)
Clin Endocrinol
, vol.39
, pp. 357-362
-
-
Cotterill, A.M.1
Holly, J.M.P.2
Wass, J.A.H.3
-
17
-
-
0023830896
-
Insulin regulates the serum levels of low molecular weight plasma insulin-like growth factor binding protein
-
Suikkari A-M, Koivisto VA, Rutanen EM, Yki-Jarvinen H, Karonen SL, Seppala R. Insulin regulates the serum levels of low molecular weight plasma insulin-like growth factor binding protein. J Clin Endocrinol Metab 1988;66:266-72.
-
(1988)
J Clin Endocrinol Metab
, vol.66
, pp. 266-272
-
-
Suikkari, A.-M.1
Koivisto, V.A.2
Rutanen, E.M.3
Yki-Jarvinen, H.4
Karonen, S.L.5
Seppala, R.6
-
18
-
-
0022494612
-
Regulation of growth hormone and somatomedin-C secretion in post-menopausal women: Effect of physiological estrogen replacement
-
Dawson-Hughes B, Stern D, Goldman J, Reichlin S. Regulation of growth hormone and somatomedin-C secretion in post-menopausal women: Effect of physiological estrogen replacement. J Clin Endocrinol Metab 1986;63:424-32.
-
(1986)
J Clin Endocrinol Metab
, vol.63
, pp. 424-432
-
-
Dawson-Hughes, B.1
Stern, D.2
Goldman, J.3
Reichlin, S.4
-
19
-
-
0026031599
-
RIA for IGF-1: Solutions to some potential problems and pitfalls
-
Brier BH, Gallaher BW, Gluckman PD. RIA for IGF-1: solutions to some potential problems and pitfalls. J Endocrinol 1991;128: 347-57.
-
(1991)
J Endocrinol
, vol.128
, pp. 347-357
-
-
Brier, B.H.1
Gallaher, B.W.2
Gluckman, P.D.3
-
20
-
-
0022467893
-
Analysis of serum insulin-like growth factor binding proteins using Western ligand blotting: Use of the method for titration of the binding proteins and competitive binding studies
-
Hossenlopp P, Seurin D, Segovia-Quinson B, Hardouin S, Binoux M. Analysis of serum insulin-like growth factor binding proteins using Western ligand blotting: use of the method for titration of the binding proteins and competitive binding studies. Anal Biochem 1986;154:138-43.
-
(1986)
Anal Biochem
, vol.154
, pp. 138-143
-
-
Hossenlopp, P.1
Seurin, D.2
Segovia-Quinson, B.3
Hardouin, S.4
Binoux, M.5
-
21
-
-
0028063571
-
Identification of insulin-like growth factor binding protein (IGFBP)-3 fragments, and IGFBP-5 proteolytic activity in human seminal plasma: A comparison of normal and vasectomized patients
-
Lee KO, Oh Y, Giudice LC, Cohen P, Peehl DM, Rosenfeld RG. Identification of insulin-like growth factor binding protein (IGFBP)-3 fragments, and IGFBP-5 proteolytic activity in human seminal plasma: a comparison of normal and vasectomized patients. J Clin Endocrinol Metab 1994;79:1367-72.
-
(1994)
J Clin Endocrinol Metab
, vol.79
, pp. 1367-1372
-
-
Lee, K.O.1
Oh, Y.2
Giudice, L.C.3
Cohen, P.4
Peehl, D.M.5
Rosenfeld, R.G.6
-
22
-
-
0021359118
-
Factors controlling blood concentrations of somatomedin-C
-
Clemmons DR, VanWyk JJ. Factors controlling blood concentrations of somatomedin-C. Clin Endocrinol Metah 1984;13:113-43.
-
(1984)
Clin Endocrinol Metah
, vol.13
, pp. 113-143
-
-
Clemmons, D.R.1
VanWyk, J.J.2
-
23
-
-
0022436729
-
The somatomedins: Insulin-like growth factors
-
Baxter RC. The somatomedins: insulin-like growth factors. Adv Clin Chem 1986;25:49-235.
-
(1986)
Adv Clin Chem
, vol.25
, pp. 49-235
-
-
Baxter, R.C.1
-
24
-
-
0022839490
-
Radioimmunoassay of growth hormonedependent insulin-like growth factor binding protein in human plasma
-
Baxter RC, Martin JL. Radioimmunoassay of growth hormonedependent insulin-like growth factor binding protein in human plasma. J Clin Invest 1986;78:1504-12.
-
(1986)
J Clin Invest
, vol.78
, pp. 1504-1512
-
-
Baxter, R.C.1
Martin, J.L.2
-
25
-
-
0027441558
-
Oestrogenic effects of adjuvant tamoxifen in post-menopausal breast cancer
-
Fornander T, Rutqvist LE, Wilking N, Carlstrom K, von Schoultz B. Oestrogenic effects of adjuvant tamoxifen in post-menopausal breast cancer. Eur J Cancer 1993;29A(4):497-500.
-
(1993)
Eur J Cancer
, vol.29 A
, Issue.4
, pp. 497-500
-
-
Fornander, T.1
Rutqvist, L.E.2
Wilking, N.3
Carlstrom, K.4
Von Schoultz, B.5
-
26
-
-
0028342709
-
Plasma insulin-like growth factor I and its binding proteins 1 and 3 in post-menopausal patients with breast cancer receiving long term tamoxifen
-
Lahti EI, Knip M, Laatikainen TJ. Plasma insulin-like growth factor I and its binding proteins 1 and 3 in post-menopausal patients with breast cancer receiving long term tamoxifen. Cancer 1994; 74:618-24.
-
(1994)
Cancer
, vol.74
, pp. 618-624
-
-
Lahti, E.I.1
Knip, M.2
Laatikainen, T.J.3
-
27
-
-
0024550730
-
Analysis of insulin-like growth factor I gene expression in malignancy: Evidence for a paracrine role in human breast cancer
-
Yee D, Paik S, Lebovic GS, et al. Analysis of insulin-like growth factor I gene expression in malignancy: Evidence for a paracrine role in human breast cancer. Mol Endocrinol 1989;3:509-17.
-
(1989)
Mol Endocrinol
, vol.3
, pp. 509-517
-
-
Yee, D.1
Paik, S.2
Lebovic, G.S.3
-
28
-
-
0030067106
-
Estradiol and antiestrogens regulate a growth inhibitory insulin-like growth factor binding protein 3 autocrine loop in human breast cancer cells
-
Huynh H, Yang X, Pollak M. Estradiol and antiestrogens regulate a growth inhibitory insulin-like growth factor binding protein 3 autocrine loop in human breast cancer cells. J Biol Chem 1996; 271:1016-21.
-
(1996)
J Biol Chem
, vol.271
, pp. 1016-1021
-
-
Huynh, H.1
Yang, X.2
Pollak, M.3
-
29
-
-
0028318558
-
Insulin-like growth factor binding protein 3 (IGF-3) inhibits estrogen-stimulated breast cancer cell proliferation
-
Pratt SE, Pollak MN. Insulin-like growth factor binding protein 3 (IGF-3) inhibits estrogen-stimulated breast cancer cell proliferation. Biochem Biophys Res Comm 1994;198:292-7.
-
(1994)
Biochem Biophys Res Comm
, vol.198
, pp. 292-297
-
-
Pratt, S.E.1
Pollak, M.N.2
-
30
-
-
0027476724
-
Transfection of the human insulin-like growth factor binding protein-3 gene into Balb/c fibroblasts inhibits cellular growth
-
Cohen P, Lamson G, Okajima T, Rosenfeld RG. Transfection of the human insulin-like growth factor binding protein-3 gene into Balb/c fibroblasts inhibits cellular growth. Mol Endocrinol 1993; 7:380-6.
-
(1993)
Mol Endocrinol
, vol.7
, pp. 380-386
-
-
Cohen, P.1
Lamson, G.2
Okajima, T.3
Rosenfeld, R.G.4
-
31
-
-
0025971180
-
Retinoid modulation of insulin-like growth factor binding proteins and inhibition of breast carcinoma proliferation
-
Fontana JA, Burrows-Mezu A, Clemmons DR, LeRoith D. Retinoid modulation of insulin-like growth factor binding proteins and inhibition of breast carcinoma proliferation. Endocrinology 1991; 128:1115-22.
-
(1991)
Endocrinology
, vol.128
, pp. 1115-1122
-
-
Fontana, J.A.1
Burrows-Mezu, A.2
Clemmons, D.R.3
LeRoith, D.4
-
32
-
-
0028243179
-
Epidermal growth factor suppresses insulin-like growth factor binding protein 3 levels in human papillomavirus type 16-immortalized cervical epithelial cells and thereby potentiates the effects of insulin-like growth factor I
-
Hembree JR, Agarwal C, Eckert RL. Epidermal growth factor suppresses insulin-like growth factor binding protein 3 levels in human papillomavirus type 16-immortalized cervical epithelial cells and thereby potentiates the effects of insulin-like growth factor I. Cancer Res 1994;54:3160-6.
-
(1994)
Cancer Res
, vol.54
, pp. 3160-3166
-
-
Hembree, J.R.1
Agarwal, C.2
Eckert, R.L.3
-
33
-
-
0027373968
-
Demonstration of receptors for insulin-like growth factor binding protein-3 on Hs578T human breast cancer cells
-
Oh Y, Müllers HL, Pham HM, Rosenfeld RG. Demonstration of receptors for insulin-like growth factor binding protein-3 on Hs578T human breast cancer cells. J Biol Chem 1993;268: 26045-8.
-
(1993)
J Biol Chem
, vol.268
, pp. 26045-26048
-
-
Oh, Y.1
Müllers, H.L.2
Pham, H.M.3
Rosenfeld, R.G.4
-
34
-
-
0026631684
-
Tissue-specific expression of insulin-like growth factor binding protein-3 protease activity during rat pregnancy
-
Davenport MI., Pucilowska J, Clemmons DR, Lundblad R, Spencer JA, Underwood LE. Tissue-specific expression of insulin-like growth factor binding protein-3 protease activity during rat pregnancy. Endocrinology 1992;130:2505-12.
-
(1992)
Endocrinology
, vol.130
, pp. 2505-2512
-
-
Davenport, M.I.1
Pucilowska, J.2
Clemmons, D.R.3
Lundblad, R.4
Spencer, J.A.5
Underwood, L.E.6
-
35
-
-
0023625418
-
Evidence that transforming growth factor- β is a hormonally regulated negative growth factor in human breast cancer cells
-
Knabbe C, Lippman ME, Wakefield LM, Flanders KC, Kasid A, Derynck R, Dickson RB. Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cells. Cell 1987;48:417-28.
-
(1987)
Cell
, vol.48
, pp. 417-428
-
-
Knabbe, C.1
Lippman, M.E.2
Wakefield, L.M.3
Flanders, K.C.4
Kasid, A.5
Derynck, R.6
Dickson, R.B.7
-
36
-
-
0028979350
-
Transforming growth factor-β-induced cell growth inhibition in human breast cancer cells is mediated through insulin-like growth factor-binding protein-3 action
-
Oh Y, Müllers HL, Ng L, Rosenfeld RG. Transforming growth factor-β-induced cell growth inhibition in human breast cancer cells is mediated through insulin-like growth factor-binding protein-3 action. J Biol Chem 1995;270:13589-92.
-
(1995)
J Biol Chem
, vol.270
, pp. 13589-13592
-
-
Oh, Y.1
Müllers, H.L.2
Ng, L.3
Rosenfeld, R.G.4
-
37
-
-
0024369203
-
Insulin-like growth factor-II (IGF-II): A potential autocrine/paracrine growth factor for human breast cancer acting via the IGF-I receptor
-
Osborne CK, Coronado E, Kitten LJ, et al. Insulin-like growth factor-II (IGF-II): a potential autocrine/paracrine growth factor for human breast cancer acting via the IGF-I receptor. Mol Endocrinol 1989;3:1701-9.
-
(1989)
Mol Endocrinol
, vol.3
, pp. 1701-1709
-
-
Osborne, C.K.1
Coronado, E.2
Kitten, L.J.3
-
38
-
-
0025166350
-
Insulin-like growth factor receptor expression and function in human breast cancer
-
Cullen KJ, Yee D, Sly WS, Perdue JF, Hampton B, Lippman ME, Rosen N. Insulin-like growth factor receptor expression and function in human breast cancer. Cancer Res 1990;50:48-53.
-
(1990)
Cancer Res
, vol.50
, pp. 48-53
-
-
Cullen, K.J.1
Yee, D.2
Sly, W.S.3
Perdue, J.F.4
Hampton, B.5
Lippman, M.E.6
Rosen, N.7
-
39
-
-
0024246997
-
IGF-II mRNA expression in human breast cancer
-
Yee D, Cullen KJ, Paik S, et al. IGF-II mRNA expression in human breast cancer. Cancer Res 1988;48:6691-6.
-
(1988)
Cancer Res
, vol.48
, pp. 6691-6696
-
-
Yee, D.1
Cullen, K.J.2
Paik, S.3
-
40
-
-
0026806159
-
The effect of endocrine therapy with medroxyprogesterone acetate, 4-hydroxyandrostenedione or tamoxifen on plasma concentrations of insulin-like growth factor (IGF)-I, IGF-II and IGFBP-I in women with advanced breast cancer
-
Reed MJ, Christodoulides A, Koistinen R, Seppala M, Teale JD, Ghilchik MW. The effect of endocrine therapy with medroxyprogesterone acetate, 4-hydroxyandrostenedione or tamoxifen on plasma concentrations of insulin-like growth factor (IGF)-I, IGF-II and IGFBP-I in women with advanced breast cancer. Int J Cancer 1992;52:208-12.
-
(1992)
Int J Cancer
, vol.52
, pp. 208-212
-
-
Reed, M.J.1
Christodoulides, A.2
Koistinen, R.3
Seppala, M.4
Teale, J.D.5
Ghilchik, M.W.6
-
41
-
-
0025884765
-
The physiological role of IGFBP-1
-
Holly JMP. The physiological role of IGFBP-1. Acta Endocrinol 1991;124:55-62.
-
(1991)
Acta Endocrinol
, vol.124
, pp. 55-62
-
-
Holly, J.M.P.1
-
42
-
-
0023786341
-
Insulin-like growth factor (IGF) and IGF binding proteins: Comparison of human serum and lymph
-
Binoux M, Hossenlopp P. Insulin-like growth factor (IGF) and IGF binding proteins: comparison of human serum and lymph. J Clin Endocrinol Metab 1988;67:509-14.
-
(1988)
J Clin Endocrinol Metab
, vol.67
, pp. 509-514
-
-
Binoux, M.1
Hossenlopp, P.2
-
43
-
-
0024592852
-
A comparison of the biological activity of the recombinant intact and truncated insulin-like growth factor I (IGF-I)
-
Carlsson-Skwirut C, Lake M, Hartmanis M, Hall K, Sara VR. A comparison of the biological activity of the recombinant intact and truncated insulin-like growth factor I (IGF-I). Biochem Biophys Acta 1989;1011:192-7.
-
(1989)
Biochem Biophys Acta
, vol.1011
, pp. 192-197
-
-
Carlsson-Skwirut, C.1
Lake, M.2
Hartmanis, M.3
Hall, K.4
Sara, V.R.5
-
44
-
-
0342476502
-
An insulin-like growth factor binding protein enhances the biologic response to IGF-I
-
Elgin RG, Busby WH Jr, Clemmons DR. An insulin-like growth factor binding protein enhances the biologic response to IGF-I. Proc Natl Acad Sci USA 1987;84:3254-8.
-
(1987)
Proc Natl Acad Sci USA
, vol.84
, pp. 3254-3258
-
-
Elgin, R.G.1
Busby Jr., W.H.2
Clemmons, D.R.3
-
45
-
-
0027476877
-
Post-translational regulation of insulin-like growth factor binding protein-4 in normal and transformed human fibroblasts
-
Conover CA, Keifer MC, Zapf J. Post-translational regulation of insulin-like growth factor binding protein-4 in normal and transformed human fibroblasts. J Clin Invest 1993;91:1129-37.
-
(1993)
J Clin Invest
, vol.91
, pp. 1129-1137
-
-
Conover, C.A.1
Keifer, M.C.2
Zapf, J.3
-
46
-
-
0026050994
-
Characterization of an insulin-like growth factor binding protein (IGFBP-4) produced by the B104 rat neuronal cell line: Chemical and biological properties and differential synthesis by sublines
-
Cheung PT, Smith EP, Shimasaki S, Ling N, Chernausek SD. Characterization of an insulin-like growth factor binding protein (IGFBP-4) produced by the B104 rat neuronal cell line: chemical and biological properties and differential synthesis by sublines. Endocrinology 1991;129:1006-15.
-
(1991)
Endocrinology
, vol.129
, pp. 1006-1015
-
-
Cheung, P.T.1
Smith, E.P.2
Shimasaki, S.3
Ling, N.4
Chernausek, S.D.5
|